If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Omvoh ™ (mirikizumab-mrkz) injection
300 mg/15 mL, 100 mg/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
VIDEO: What is the mechanism of action of mirikizumab in inflammatory bowel disease?
Mirikizumab is a humanized monoclonal antibody directed against interleukin-23, a key cytokine in the inflammatory process of IBD.
Date of Last Review: April 10, 2023
Document Number: VV-MED-139353